Eric van Cutsem
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Eric van Cutsem
Jun 28, 2024, 08:19 |
Societies
15 Posts You Should Not Miss From The 1st Day of ESMOGI24
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…
May 15, 2024, 13:47 |
Societies
Interview with Eric Van Cutsem and Zorana Maravic on the ESMO Daily Reporter - ESMO
The European Society for Medical Oncology (ESMO) shared on X: “While novel agents continue to…
May 10, 2024, 17:49 |
Drugs
Piotr Wysocki: Relatlimab does not improve the activity of nivolumab plus chemotherapy
Piotr Wysocki recently posted on LinkedIn: "RELATIVITY-060 was an open-label phase II study investigating the…
Apr 29, 2024, 15:33 |
Blog
Lucjan Wyrwicz: European perspective of OMEC-4 survey
Lucjan Wyrwicz, Medical Oncologist at Maria Curie National Cancer Research Institute in Warsaw, Poland, recently…
All:
4
Posts:
1 - 10
Monica Bertagnolli: Molecular Portrait of Key Driver of pancreatic cancer
We need to hurry up, because cancer and patients cannot wait!
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
Facebook
RSS Feed
Twitter
Linkedin
Youtube